Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT04478695
Eligibility Criteria:
Key Inclusion criteria
* AML as defined by the WHO Classification persisting or recurring following one or more treatment courses. Except APL
* Eastern Cooperative Oncology Group (ECOG) ≤1
Key Exclusion criteria
* Active extramedullary AML in the central nervous system.
* Known hypersensitivity to immunoglobulins.
* Non-manageable graft versus host disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT04478695
Study Brief:
Protocol Section:
NCT04478695